BUFFALO GROVE, Ill. -- Akorn today announced that the U.S. Food and Drug Administration (FDA) has granted approval for Akorn’s Abbreviated New Drug Application (ANDA) for Ofloxacin Ophthalmic ...

BUFFALO GROVE, Ill. — Akorn's abbreviated new drug application for ofloxacin ophthalmic solution 0.3% has been approved by the U.S. Food and Drug Administration, the company announced in a press ...

Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its ...

FDC Limited has announced to the exchanges regarding receipt of ANDA approval for Ofloxacin Otic Solution, 0.3%. In a regulatory filing, the company said that it has been granted ANDA approval by ...

https://www.thehindubusinessline.com/markets/caplin-point-labs-subsidiary-gets-usfda-approval-for-ofloxacin-otic-solution-03/article67718608.ece Copy Caplin Point ...